Maynard Um
-
-
-
-
-
-
-
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
-
-
-
-
-
-
-
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
-
-
-
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
enVVeno Medical (NVNO) Halted, News Pending
-
-
-
-
-
-
-
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
-
-
-
-
-
-
-
enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment
-
-
-
-
-
-
-
enVVeno Medical (NVNO): Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting
-
418,491 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

